Topic: Medicare

Medicare confirms changes in anemia drug use

Reuters US Online Report Health News - 113 days ago
LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of Epogen, the anemia drug sold ...
Read More...

Medicare proposes change in anemia drug usage

Reuters US Online Report Health News - 235 days ago
LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of Epogen, the anemia drug sold by Amgen.The government ...
Read More...

$2 billion a year

Wall Street Journal Health Blog - 1202 days ago
Medicare could scrap a payment system that some critics say encourages dialysis centers to give kidney patients more anemia drugs than they need. On Capitol Hill today, acting Medicare chief Leslie Norwalk told a House committee that the agency could begin paying ...

Cancer doctors push Medicare to ease restrictions on Amgen and Johnson & Johnson anemia drugs

AP Features - 1636 days ago
Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.The American Society of Clinical Oncology says guidelines ...
Read More...